Loading…

Hospital-Based Study of the Economic Burden Associated with Rotavirus Diarrhea in Hong Kong

Background Rotavirus infection is the most common cause of severe diarrhea in both developed and developing countries. Methods To estimate the economic burden associated with rotavirus infection in Hong Kong, we combined data on the disease burden of rotavirus-associated hospital admissions with det...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2005-09, Vol.192 (Supplement-1), p.S64-S70
Main Authors: Nelson, E. Anthony S., Tam, John S., Yu, Ly-Mee, Ng, Ying-Chu, Bresee, Joseph S., Poon, Kin-Hung, Ng, Chi-Hang, Ip, Kin-Sing, Mast, T. Christopher, Chan, Paul K.-S., Parashar, Umesh D., Fok, Tai-Fai, Glass, Roger I.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Rotavirus infection is the most common cause of severe diarrhea in both developed and developing countries. Methods To estimate the economic burden associated with rotavirus infection in Hong Kong, we combined data on the disease burden of rotavirus-associated hospital admissions with detailed cost data for a subsample of 471 children with diarrhea admitted to hospitals. Results The annual total social cost and total direct medical cost for rotavirus-associated admissions were calculated as US $4.3 and US $4 million, respectively, by use of data collected during March 2001 to March 2003. The estimate of the direct medical costs was ∼4-fold higher than a previous estimate; this difference largely reflects the greater disease burden identified through active disease surveillance conducted under the auspices of the Asian Rotavirus Surveillance Network. On average, families spent US $120 when their child's admission was associated with rotavirus infection; this cost represents ∼10% of the monthly salary of an unskilled or service worker. Conclusions These data emphasize the potential for a safe and effective rotavirus vaccine to reduce the economic burden associated with rotavirus disease.
ISSN:0022-1899
1537-6613
DOI:10.1086/431493